Arkolith/Insider Trading/VIR/Form 4

SVF Endurance (Cayman) Ltd

10% OwnerVir Biotechnology, Inc. (VIR) · full profile →Form 4 · filed Nov 26, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$2.9M
Net Open-Market Flow
-$2.9M
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 25, 2025Sell(S)236K$6.38$1.5M14.1M
Nov 24, 2025Sell(S)228K$6.15$1.4M14.3M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001493152-25-025161) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML